1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Bolin, K.A.
Anderson, D.J.
Trulson, J.A.
Thompson, D.A.
Wilken, J.
Kent, S.B.H.
Millhauser, G.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
FEBS Lett.
FEBLAL
0165
0014-5793
451
125
131
10.1016/S0014-5793(99)00553-0
10371151
NMR structure of a minimized human agouti related protein prepared by total chemical synthesis.
1999
US
Mol.Endocrinol.
MOENEN
2068
0888-8809
13
148
155
10.1210/me.13.1.148
Characterization of Agouti-Related Protein Binding to Melanocortin Receptors.
1999
US
Biochemistry
BICHAW
0033
0006-2960
37
12172
12177
10.1021/bi981082v
Determination of Disulfide Structure in Agouti-Related Protein (Agrp) by Stepwise Reduction and Alkylation
1998
10.2210/pdb1hyk/pdb
pdb_00001hyk
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
5207.157
AGOUTI RELATED PROTEIN
C-TERMINAL DOMAIN AC-AGRP(87-132)
1
syn
polymer
no
no
CVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTAMNPCSRT
CVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTAMNPCSRT
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-02-07
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
2001-02-07
SPRSDE
500 MHz NMR structure of Ac-AGRP(87-132) {referred to as MARP or minimized agouti related protein}
RCSB
Y
RCSB
2001-01-19
REL
This sequence is the native sequence for the cystine-rich C-terminal domain of the human agouti-related protein. The N-terminal acetylation at residue 87 (the first residue of the sequence) is non-native and done only to prevent a non-native positively charged amino terminus in the synthetic fragment. Synthesis was by means of standard BOC-based solid-phase peptide synthesis followed by refolding and oxidation of cysteines to cystines.
sample
STANDARD 2D HOMONUCLEAR TECHNIQUES WERE USED TO ASSIGN SPECTRA ACQUIRED OVER THE TEMPERATURE RANGE 288- 303 K. A SUBSET OF UNAMBIGUOUSLY ASSIGNED NOE PEAKS TAKEN FROM DATA ACQUIRED AT 288 K WITH AN 150 MS MIXING TIME WERE USED IN STRUCTURE CALCULATIONS, AS WERE 34 PHI BACKBONE ANGLE RESTRAINTS DERIVED FROM FITTING OF DQF- COSY CROSSPEAKS. BOTH CARRIER PRESATURATION AND Z- GRADIENT WET TECHNIQUES WERE USED FOR SOLVENT SUPPRESSION. New experiments from 1qu8 are E-COSY at 500 MHz and 150 msec 2D-NOESY at 800 MHz, 288K.
see refinement method and details
40
40
2D-NOESY
DQF-COSY
E-COSY
50mM PHOSPHATE
5.00
1
atm
288.00
K
The preliminary structure calculation and restraint quality assessment was performed in DYANA v 1.5, so that out of 200 structures the 20 with the lowest target functions would have target function vaules of < 3.0 square angstroms. The lowest target function structure of this family was then submitted as a pre-folded structure in CNS v. 1.0, and 40 structures calculated under cool (< 288K) simulated annealing and conjugate gradient energy minimization. These calculations were carried out in the presence of experimnetal NOE and J-coupling restraints as well as assigned hydrogen bonds consistent with HX protection. DYANA 1.5: 799 unique NOE's from 800 MHz data, 444 resulting distance restraints after pseudoatom calculation/replacement and removal of NOE's between atoms separated by only two or three bonds. 35 alpha-H to amide-H 3-bond J-coupling constants and 44 alpha-H to beta-H 3-bond J-coupling constants from ECOSY data were also included. Disulfides and seven hydrogen bonds as determinied from surrounding NOE's and HX data were included as pseudo-NOE restraints. CNS 1.0, patch level 0: 504 distance restraints from 800 MHz NOE data, corresponding to the same upper limit restraints as used in the final round of DYANA 1.5 calulations (conversion using AQUA 2.0 in PROCHECK_NMR, and modified lower limit of 1.6 angstroms was imposed on all NOE restraints while keeping upper bounds). Disulfide map was incorporated into the covalent structure of the molecule and thereby strictly enforced in this step. The seven hydrogen bonds were included in a separate restraint file. 34 alpha-H to amide-H 3-bond J-coupling constants (not including CYS-87 amide mesurement) were also included. 40 structures were so calculated and all are deposited here.
torsion angle dynamics
10
lowest energy
1.9 MM Ac-AGRP(87-132) (same as 1.9 MM MARP of 1qu8)
50 MM PHOSPHATE BUFFER PH 5.0 (pH is changed from pH=4.2 in 1qu8)
A.T.BRUNGER, P.D.ADAMS, G.M.CLORE, W.L.DELANO, P.GROS, R.W.GROSSE-KUNSTLEVE, J.-S.JIANG, J.KUSZEWSKI, M.NILGES, N.S.PANNU, R.J.READ, L.M.RICE, T.SIMONSON, G.L.WARREN
refinement
CNS
1.0
F. Vosman, D. Iverson, S. Patt, S. Chetham, R. Lasater, P. Hornung, G. Brissey, E. Williams, B. John, C. H. Yoder, B. L. Buckwalter
collection
VNMR
5.2
M. Kjear, K.V. Andersoen, C. Rischel
processing
MNMR
940501
T. Xia, C. Bartels
data analysis
XEASY
1.2
P. Guntert, C. Mumenthaler, T. Herrmann
structure solution
DYANA
1.5
Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M., Rullmann J. A. C.
processing
PROCHECK
3.4.4
800
Varian
UNITYPLUS
CYS
1
n
1
CYS
1
A
VAL
2
n
2
VAL
2
A
ARG
3
n
3
ARG
3
A
LEU
4
n
4
LEU
4
A
HIS
5
n
5
HIS
5
A
GLU
6
n
6
GLU
6
A
SER
7
n
7
SER
7
A
CYS
8
n
8
CYS
8
A
LEU
9
n
9
LEU
9
A
GLY
10
n
10
GLY
10
A
GLN
11
n
11
GLN
11
A
GLN
12
n
12
GLN
12
A
VAL
13
n
13
VAL
13
A
PRO
14
n
14
PRO
14
A
CYS
15
n
15
CYS
15
A
CYS
16
n
16
CYS
16
A
ASP
17
n
17
ASP
17
A
PRO
18
n
18
PRO
18
A
CYS
19
n
19
CYS
19
A
ALA
20
n
20
ALA
20
A
THR
21
n
21
THR
21
A
CYS
22
n
22
CYS
22
A
TYR
23
n
23
TYR
23
A
CYS
24
n
24
CYS
24
A
ARG
25
n
25
ARG
25
A
PHE
26
n
26
PHE
26
A
PHE
27
n
27
PHE
27
A
ASN
28
n
28
ASN
28
A
ALA
29
n
29
ALA
29
A
PHE
30
n
30
PHE
30
A
CYS
31
n
31
CYS
31
A
TYR
32
n
32
TYR
32
A
CYS
33
n
33
CYS
33
A
ARG
34
n
34
ARG
34
A
LYS
35
n
35
LYS
35
A
LEU
36
n
36
LEU
36
A
GLY
37
n
37
GLY
37
A
THR
38
n
38
THR
38
A
ALA
39
n
39
ALA
39
A
MET
40
n
40
MET
40
A
ASN
41
n
41
ASN
41
A
PRO
42
n
42
PRO
42
A
CYS
43
n
43
CYS
43
A
SER
44
n
44
SER
44
A
ARG
45
n
45
ARG
45
A
THR
46
n
46
THR
46
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
TYR
23
A
N
TYR
23
A
O
TYR
32
A
O
TYR
32
1
A
ARG
3
-79.70
-163.56
1
A
HIS
5
-155.85
77.69
1
A
LEU
9
22.32
99.52
1
A
PHE
26
-145.45
-154.76
1
A
PHE
27
-55.65
-71.00
1
A
ASN
28
-155.19
75.87
1
A
ALA
29
-153.09
-61.57
1
A
LEU
36
60.61
111.15
1
A
ASN
41
-150.26
69.41
1
A
CYS
43
-82.29
-118.34
1
A
ARG
45
-154.85
66.27
2
A
ARG
3
-79.73
-169.36
2
A
HIS
5
-154.69
71.84
2
A
LEU
9
18.18
98.90
2
A
GLN
11
74.89
-31.56
2
A
PHE
26
-145.38
-155.22
2
A
ASN
28
-156.08
83.44
2
A
ALA
29
-150.82
-77.37
2
A
LEU
36
58.47
109.01
2
A
ASN
41
-150.19
69.41
2
A
CYS
43
-81.51
-116.64
3
A
ARG
3
-78.57
-166.38
3
A
HIS
5
-154.91
68.03
3
A
LEU
9
23.70
93.07
3
A
GLN
11
74.59
-51.70
3
A
GLN
12
-90.55
36.92
3
A
ASN
28
-154.17
74.07
3
A
ALA
29
-152.06
-60.83
3
A
LEU
36
59.74
110.30
3
A
ASN
41
-150.47
68.15
3
A
CYS
43
-81.80
-116.88
3
A
ARG
45
-154.91
82.60
4
A
ARG
3
-79.29
-168.12
4
A
HIS
5
-153.28
69.61
4
A
LEU
9
23.96
91.52
4
A
GLN
11
75.26
-52.71
4
A
CYS
19
59.00
15.67
4
A
PHE
26
-145.06
-156.35
4
A
ASN
28
-156.03
80.24
4
A
ALA
29
-151.87
-71.72
4
A
LEU
36
60.49
110.37
4
A
ASN
41
-150.17
65.98
4
A
CYS
43
-82.30
-119.34
5
A
HIS
5
-155.84
71.11
5
A
LEU
9
26.74
93.75
5
A
GLN
11
72.29
-3.07
5
A
PHE
26
-145.09
-155.06
5
A
ASN
28
-156.39
83.66
5
A
ALA
29
-150.81
-79.91
5
A
LEU
36
58.94
109.39
5
A
CYS
43
-82.21
-117.62
5
A
ARG
45
-155.26
82.63
6
A
ARG
3
-76.68
-163.09
6
A
HIS
5
-155.25
52.98
6
A
LEU
9
25.25
94.81
6
A
PHE
26
-144.53
-155.00
6
A
ASN
28
-155.75
79.45
6
A
ALA
29
-152.27
-67.92
6
A
LEU
36
60.07
110.74
6
A
ASN
41
-150.08
71.35
6
A
CYS
43
-82.31
-118.10
6
A
ARG
45
-155.10
86.24
7
A
HIS
5
-86.06
47.51
7
A
LEU
9
25.85
84.72
7
A
PHE
26
-145.75
-155.77
7
A
ASN
28
-156.01
83.54
7
A
ALA
29
-150.56
-76.69
7
A
LYS
35
-83.60
35.87
7
A
LEU
36
54.89
107.40
7
A
ASN
41
-150.12
74.59
7
A
CYS
43
-82.03
-117.44
7
A
ARG
45
-154.94
74.03
8
A
ARG
3
-79.51
-166.93
8
A
HIS
5
-156.29
70.90
8
A
LEU
9
15.57
106.77
8
A
CYS
19
59.12
16.10
8
A
PHE
26
-146.08
-156.86
8
A
ASN
28
-155.09
79.97
8
A
ALA
29
-152.10
-70.76
8
A
LYS
35
-84.46
35.58
8
A
LEU
36
56.88
108.75
8
A
ASN
41
-150.17
72.50
8
A
CYS
43
-82.59
-119.06
8
A
ARG
45
-154.93
78.56
9
A
ARG
3
-79.47
-166.78
9
A
HIS
5
-155.64
72.53
9
A
LEU
9
22.54
82.09
9
A
GLN
11
77.34
-38.42
9
A
GLN
12
-89.22
34.76
9
A
PHE
26
-145.31
-155.02
9
A
ASN
28
-156.80
84.29
9
A
ALA
29
-149.90
-82.57
9
A
LEU
36
56.88
108.29
9
A
ASN
41
-150.56
71.71
9
A
CYS
43
-82.45
-117.98
9
A
ARG
45
-155.13
43.96
10
A
ARG
3
-78.71
-165.22
10
A
HIS
5
-155.63
65.82
10
A
LEU
9
23.42
94.49
10
A
GLN
11
74.03
-54.41
10
A
PHE
26
-146.21
-158.53
10
A
ASN
28
-155.10
78.42
10
A
ALA
29
-152.06
-69.57
10
A
LEU
36
61.03
111.44
10
A
ASN
41
-150.16
67.74
10
A
CYS
43
-82.07
-117.22
10
A
ARG
45
-154.99
36.98
11
A
ARG
3
-78.66
-164.72
11
A
HIS
5
-156.66
75.72
11
A
LEU
9
15.01
104.36
11
A
PHE
26
-145.37
-156.55
11
A
ASN
28
-155.00
81.23
11
A
ALA
29
-151.31
-73.20
11
A
LEU
36
58.73
109.80
11
A
ASN
41
-151.85
70.28
11
A
CYS
43
-81.76
-116.81
12
A
ARG
3
-78.54
-165.04
12
A
HIS
5
-154.86
75.33
12
A
LEU
9
23.53
94.73
12
A
GLN
11
76.48
-23.24
12
A
GLN
12
-94.60
32.25
12
A
PHE
26
-145.87
-154.83
12
A
ASN
28
-155.40
82.79
12
A
ALA
29
-151.65
-75.84
12
A
LEU
36
60.89
110.26
12
A
CYS
43
-82.15
-117.74
12
A
ARG
45
-154.84
82.08
13
A
ARG
3
-78.04
-163.14
13
A
HIS
5
-155.23
81.26
13
A
LEU
9
24.58
97.26
13
A
GLN
11
57.51
18.99
13
A
PHE
26
-142.99
-157.43
13
A
ASN
28
-156.30
83.15
13
A
ALA
29
-151.01
-80.26
13
A
LYS
35
-85.69
30.73
13
A
LEU
36
54.78
106.24
13
A
ASN
41
-150.31
78.26
13
A
CYS
43
-82.24
-117.98
13
A
ARG
45
-154.83
78.13
14
A
ARG
3
-78.73
-165.16
14
A
HIS
5
-154.75
72.46
14
A
LEU
9
26.24
94.20
14
A
GLN
11
74.81
-11.87
14
A
PHE
26
-144.58
-156.18
14
A
ASN
28
-156.21
81.69
14
A
ALA
29
-152.63
-72.78
14
A
LYS
35
-83.94
30.09
14
A
LEU
36
55.97
108.05
14
A
ASN
41
-150.02
63.82
14
A
CYS
43
-82.29
-118.08
14
A
ARG
45
-154.98
34.56
15
A
ARG
3
-78.42
-168.38
15
A
HIS
5
-156.64
74.63
15
A
LEU
9
24.56
94.59
15
A
CYS
19
57.58
17.35
15
A
PHE
26
-145.63
-154.73
15
A
ASN
28
-155.95
82.95
15
A
ALA
29
-151.78
-74.99
15
A
LEU
36
61.47
111.20
15
A
ASN
41
-150.81
67.06
15
A
CYS
43
-82.87
-120.35
16
A
ARG
3
-79.26
-167.25
16
A
HIS
5
-156.06
41.31
16
A
LEU
9
26.36
95.03
16
A
PHE
26
-146.14
-157.10
16
A
ASN
28
-155.45
82.12
16
A
ALA
29
-151.75
-75.17
16
A
LEU
36
59.57
110.14
16
A
CYS
43
-82.13
-117.48
16
A
ARG
45
-154.96
88.30
17
A
ARG
3
-76.34
-165.79
17
A
HIS
5
-155.29
72.85
17
A
LEU
9
25.13
90.98
17
A
GLN
11
77.12
-37.16
17
A
GLN
12
-92.57
36.84
17
A
PHE
26
-144.60
-156.56
17
A
PHE
27
-56.03
-70.11
17
A
ASN
28
-154.93
76.42
17
A
ALA
29
-152.46
-66.32
17
A
LYS
35
-84.88
31.45
17
A
LEU
36
57.95
109.24
17
A
ASN
41
-150.10
75.37
17
A
CYS
43
-82.24
-117.84
17
A
ARG
45
-155.14
70.90
18
A
ARG
3
-79.61
-167.52
18
A
HIS
5
-156.10
71.70
18
A
LEU
9
25.26
95.20
18
A
GLN
11
73.13
-7.18
18
A
PHE
26
-144.08
-155.49
18
A
PHE
27
-55.59
-71.45
18
A
ASN
28
-155.50
74.06
18
A
ALA
29
-152.99
-58.83
18
A
LYS
35
-84.42
31.85
18
A
LEU
36
55.50
107.48
18
A
ASN
41
-150.45
76.67
18
A
CYS
43
-82.19
-117.66
18
A
ARG
45
-155.17
84.06
19
A
LEU
9
29.44
89.13
19
A
PHE
26
-143.54
-157.89
19
A
PHE
27
-56.20
-70.82
19
A
ASN
28
-155.39
68.22
19
A
ALA
29
-153.27
-50.57
19
A
LYS
35
-83.60
33.12
19
A
LEU
36
51.93
104.98
19
A
ASN
41
-150.36
78.30
19
A
CYS
43
-82.56
-119.46
20
A
HIS
5
-154.07
66.74
20
A
LEU
9
22.59
93.47
20
A
GLN
11
75.32
-47.92
20
A
GLN
12
-90.35
36.83
20
A
PHE
26
-145.14
-158.72
20
A
ASN
28
-154.38
81.85
20
A
ALA
29
-152.56
-74.98
20
A
LEU
36
58.44
109.07
20
A
ASN
41
-150.30
65.84
20
A
CYS
43
-81.98
-117.69
20
A
ARG
45
-154.92
88.51
21
A
HIS
5
-155.31
65.41
21
A
LEU
9
22.91
91.42
21
A
GLN
11
70.33
-47.14
21
A
PHE
26
-144.81
-158.69
21
A
ASN
28
-155.44
81.47
21
A
ALA
29
-152.39
-75.12
21
A
LEU
36
60.87
111.74
21
A
ASN
41
-150.36
67.72
21
A
CYS
43
-82.29
-118.18
21
A
ARG
45
-154.85
56.32
22
A
ARG
3
-78.82
-167.18
22
A
HIS
5
-155.50
69.59
22
A
LEU
9
24.48
95.21
22
A
GLN
11
73.55
-5.48
22
A
PHE
26
-145.60
-155.75
22
A
ASN
28
-154.87
81.53
22
A
ALA
29
-151.76
-72.68
22
A
LEU
36
60.82
110.94
22
A
ASN
41
-150.04
66.90
22
A
CYS
43
-82.01
-117.41
22
A
ARG
45
-154.66
42.68
23
A
ARG
3
-78.64
-166.42
23
A
HIS
5
-155.13
70.42
23
A
LEU
9
27.07
95.73
23
A
PHE
26
-146.68
-156.03
23
A
ASN
28
-155.68
83.86
23
A
ALA
29
-149.95
-78.00
23
A
LEU
36
58.71
109.26
23
A
ASN
41
-150.03
75.20
23
A
CYS
43
-82.16
-117.42
24
A
ARG
3
-78.98
-169.23
24
A
HIS
5
-156.07
67.94
24
A
LEU
9
23.59
87.09
24
A
GLN
11
78.19
-30.50
24
A
PHE
26
-143.92
-158.45
24
A
ASN
28
-155.16
75.48
24
A
ALA
29
-153.09
-63.98
24
A
LEU
36
60.80
111.53
24
A
ASN
41
-150.11
78.02
24
A
CYS
43
-82.50
-118.89
25
A
ARG
3
-78.08
-164.37
25
A
HIS
5
-154.84
39.42
25
A
LEU
9
17.15
99.13
25
A
GLN
11
74.43
-48.30
25
A
GLN
12
-90.47
36.80
25
A
PHE
26
-145.40
-154.25
25
A
ASN
28
-156.13
83.50
25
A
ALA
29
-151.11
-77.55
25
A
LEU
36
61.06
110.89
25
A
ASN
41
-150.11
65.22
25
A
CYS
43
-81.80
-117.38
25
A
ARG
45
-155.06
30.86
26
A
ARG
3
-77.71
-162.40
26
A
HIS
5
-156.54
75.54
26
A
LEU
9
23.83
91.68
26
A
GLN
11
75.42
-50.70
26
A
PHE
26
-144.32
-154.89
26
A
PHE
27
-55.77
-70.37
26
A
ASN
28
-155.97
78.11
26
A
ALA
29
-152.50
-66.76
26
A
LEU
36
57.24
108.31
26
A
ASN
41
-150.86
74.39
26
A
CYS
43
-81.87
-117.50
26
A
ARG
45
-155.16
86.91
27
A
ARG
3
-78.25
-164.51
27
A
HIS
5
-156.36
75.23
27
A
LEU
9
25.79
94.01
27
A
PHE
26
-143.85
-158.11
27
A
ASN
28
-155.76
80.18
27
A
ALA
29
-151.01
-71.38
27
A
LEU
36
59.57
110.49
27
A
ASN
41
-150.38
66.97
27
A
CYS
43
-82.30
-118.48
27
A
ARG
45
-155.03
40.97
28
A
ARG
3
-79.42
-164.59
28
A
HIS
5
-155.46
71.42
28
A
LEU
9
92.67
116.94
28
A
GLN
11
47.01
28.01
28
A
PHE
26
-145.81
-155.78
28
A
ASN
28
-156.18
83.02
28
A
ALA
29
-151.66
-77.26
28
A
LEU
36
59.91
110.89
28
A
ASN
41
-150.16
66.31
28
A
CYS
43
-81.76
-116.77
28
A
ARG
45
-154.86
86.50
29
A
ARG
3
-78.14
-168.12
29
A
HIS
5
-154.92
71.63
29
A
LEU
9
29.33
41.29
29
A
GLN
11
71.41
-58.08
29
A
PHE
26
-144.82
-158.73
29
A
ASN
28
-154.68
78.91
29
A
ALA
29
-152.61
-66.68
29
A
LEU
36
61.21
111.10
29
A
ASN
41
-150.31
61.39
29
A
CYS
43
-81.56
-116.35
29
A
ARG
45
-154.56
67.79
30
A
HIS
5
-154.74
44.83
30
A
LEU
9
26.45
93.91
30
A
PHE
26
-145.24
-155.00
30
A
ASN
28
-155.97
81.48
30
A
ALA
29
-152.01
-73.19
30
A
LEU
36
60.46
111.38
30
A
ASN
41
-150.34
67.00
30
A
CYS
43
-82.46
-118.71
30
A
ARG
45
-154.86
87.56
31
A
HIS
5
-85.35
48.48
31
A
LEU
9
27.38
41.96
31
A
GLN
11
70.35
-58.73
31
A
GLN
12
-91.24
36.02
31
A
PHE
26
-145.94
-155.50
31
A
ASN
28
-155.97
83.26
31
A
ALA
29
-151.20
-74.65
31
A
LYS
35
-84.72
40.81
31
A
LEU
36
49.98
103.62
31
A
ASN
41
-150.35
75.26
31
A
CYS
43
-81.60
-117.94
31
A
ARG
45
-154.93
85.64
32
A
ARG
3
-79.61
-168.26
32
A
HIS
5
-155.47
66.72
32
A
LEU
9
25.19
96.04
32
A
PHE
26
-146.13
-154.57
32
A
ASN
28
-155.02
79.33
32
A
ALA
29
-153.36
-66.21
32
A
LEU
36
60.57
111.12
32
A
CYS
43
-81.89
-117.37
33
A
ARG
3
-77.99
-169.42
33
A
HIS
5
-155.39
72.19
33
A
LEU
9
24.37
88.19
33
A
GLN
11
76.55
-37.58
33
A
GLN
12
-90.01
34.89
33
A
PHE
26
-144.43
-154.81
33
A
PHE
27
-55.51
-70.58
33
A
ASN
28
-155.77
78.21
33
A
ALA
29
-152.79
-65.29
33
A
LYS
35
-84.61
33.91
33
A
LEU
36
57.41
109.20
33
A
ASN
41
-150.45
71.93
33
A
CYS
43
-82.25
-117.29
33
A
ARG
45
-155.24
31.07
34
A
ARG
3
-78.70
-164.60
34
A
HIS
5
-155.69
46.08
34
A
LEU
9
25.67
92.64
34
A
GLN
11
73.40
-7.69
34
A
PHE
26
-144.02
-154.41
34
A
PHE
27
-55.37
-71.54
34
A
ASN
28
-155.91
77.32
34
A
ALA
29
-152.80
-64.19
34
A
LEU
36
57.79
109.17
34
A
ASN
41
-150.35
73.21
34
A
CYS
43
-82.23
-117.21
35
A
ARG
3
-78.59
-165.08
35
A
HIS
5
-155.47
75.47
35
A
LEU
9
26.18
95.40
35
A
PHE
26
-145.26
-155.15
35
A
ASN
28
-155.84
80.77
35
A
ALA
29
-152.86
-70.74
35
A
LYS
35
-83.19
49.71
35
A
LEU
36
48.55
103.75
35
A
ASN
41
-150.13
79.36
35
A
CYS
43
-82.08
-117.55
35
A
ARG
45
-154.84
64.05
36
A
ARG
3
-78.02
-166.86
36
A
HIS
5
-154.78
68.21
36
A
LEU
9
22.26
93.36
36
A
GLN
11
74.24
-52.25
36
A
PHE
26
-144.28
-159.09
36
A
ASN
28
-154.97
76.72
36
A
ALA
29
-152.49
-65.39
36
A
LEU
36
58.55
109.08
36
A
ASN
41
-150.07
73.22
36
A
CYS
43
-81.41
-116.15
36
A
ARG
45
-154.93
77.91
37
A
ARG
3
-79.10
-165.09
37
A
HIS
5
-154.92
68.90
37
A
LEU
9
22.13
95.36
37
A
GLN
11
71.06
-55.11
37
A
GLN
12
-91.29
38.32
37
A
PHE
26
-145.29
-159.07
37
A
ASN
28
-155.14
74.17
37
A
ALA
29
-152.56
-62.18
37
A
LEU
36
61.49
110.81
37
A
ASN
41
-150.16
64.66
37
A
CYS
43
-81.73
-116.91
37
A
ARG
45
-154.98
82.61
38
A
ARG
3
-78.12
-162.52
38
A
HIS
5
-154.81
47.33
38
A
LEU
9
24.25
94.58
38
A
PHE
26
-145.94
-155.54
38
A
ASN
28
-154.46
80.32
38
A
ALA
29
-153.05
-70.29
38
A
LEU
36
61.65
111.35
38
A
ASN
41
-150.16
73.10
38
A
CYS
43
-82.38
-118.10
38
A
ARG
45
-154.85
31.89
39
A
ARG
3
-78.62
-166.12
39
A
HIS
5
-156.33
40.20
39
A
LEU
9
25.87
93.10
39
A
GLN
11
74.54
-14.20
39
A
PHE
26
-142.77
-157.00
39
A
ASN
28
-155.91
80.69
39
A
ALA
29
-152.10
-70.73
39
A
LEU
36
58.97
109.37
39
A
ASN
41
-150.33
73.87
39
A
CYS
43
-82.17
-117.82
39
A
ARG
45
-155.09
60.74
40
A
ARG
3
-78.22
-169.47
40
A
HIS
5
-154.89
69.87
40
A
LEU
9
22.45
95.88
40
A
GLN
11
74.45
-6.30
40
A
GLN
12
-96.12
34.94
40
A
PHE
26
-144.93
-155.97
40
A
ASN
28
-155.45
75.57
40
A
ALA
29
-152.82
-59.35
40
A
LEU
36
61.06
110.72
40
A
ASN
41
-150.22
69.00
40
A
CYS
43
-81.90
-117.46
AGOUTI-RELATED PROTEIN (87-132) (AC-AGRP(87-132))
1
N
N
disulf
2.033
A
CYS
1
A
SG
CYS
1
1_555
A
CYS
16
A
SG
CYS
16
1_555
disulf
2.029
A
CYS
8
A
SG
CYS
8
1_555
A
CYS
22
A
SG
CYS
22
1_555
disulf
2.029
A
CYS
15
A
SG
CYS
15
1_555
A
CYS
33
A
SG
CYS
33
1_555
disulf
2.030
A
CYS
19
A
SG
CYS
19
1_555
A
CYS
43
A
SG
CYS
43
1_555
disulf
2.030
A
CYS
24
A
SG
CYS
24
1_555
A
CYS
31
A
SG
CYS
31
1_555
SIGNALING PROTEIN
CYSTEINE RICH; DISULFIDE BOND, ICK, INHIBITOR CYSTINE KNOT, MELANOCORTIN ANTAGONISTS, AGOUTI, AGOUTI-RELATED, AGRP, ENDOGENOUS ANTAGONIST, SIGNALING PROTEIN
AGRP_HUMAN
UNP
1
87
O00253
CVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTAMNPCSRT
87
132
1HYK
1
46
O00253
A
1
1
46
2
anti-parallel
A
THR
21
A
THR
21
A
CYS
24
A
CYS
24
A
CYS
31
A
CYS
31
A
ARG
34
A
ARG
34
1
P 1